Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 131.20 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 6:28 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

lincoln pharmaceuticals ltd (LPH) Snapshot

Open
134.10
Previous Close
132.00
Day High
144.00
Day Low
130.00
52 Week High
08/20/15 - 168.90
52 Week Low
10/20/14 - 42.00
Market Cap
2.1B
Average Volume 10 Days
1.1M
EPS TTM
9.20
Shares Outstanding
16.3M
EX-Date
--
P/E TM
14.3x
Dividend
1.00
Dividend Yield
0.46%
Current Stock Chart for LINCOLN PHARMACEUTICALS LTD (LPH)

Related News

No related news articles were found.

lincoln pharmaceuticals ltd (LPH) Related Businessweek News

No Related Businessweek News Found

lincoln pharmaceuticals ltd (LPH) Details

Lincoln Pharmaceuticals Ltd. manufactures, markets, and exports pharmaceutical products in India and internationally. The company’s product categories include antimalarial, antibiotics, anti-bactarials, analgesics, anti-inflammatory, anti-pyretics, anti-hypertensives, anti-fungal, antacids, anti-ulcers, anthelmintics, anti-cold, anti-allergic, anti-asthmatics, anti-emetics, gastrointestinal-agents, anti-diarrhoeals, anti-spasmodics, and pro-biotics, as well as cardiac and diuretic products. It also provides creams, ointments, anti-infectives, vitamins, minerals, and iron-preparations. In addition, the company trades finished goods, chemicals products, and bulk drugs. The company was founded in 1979 and is based in Ahmedabad, India.

Founded in 1979

lincoln pharmaceuticals ltd (LPH) Top Compensated Officers

Joint Managing Director and Director
Total Annual Compensation: 1.2M
Managing Director, Whole Time Director, Membe...
Total Annual Compensation: 1.2M
Whole-Time Director and Member of Shareholder...
Total Annual Compensation: 1.2M
Compliance Officer and Member of Shareholders...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

lincoln pharmaceuticals ltd (LPH) Key Developments

Lincoln Pharmaceuticals Ltd. Reports Unaudited Consolidated and Standalone Earnings Results for the First Quarter Ended June 30, 2015

Lincoln Pharmaceuticals Ltd. reported unaudited consolidated and standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the group reported net sales of INR 732.341 million, profit from operations before other income, finance costs and exceptional items of INR 103.040 million, profit from ordinary activities before tax of INR 83.15 million and net profit of INR 65.454 million or INR 4.01 per diluted share after extraordinary items (not annualised) compared to net sales of INR 469.495 million, profit from operations before other income, finance costs and exceptional items of INR 60.593 million, profit from ordinary activities before tax of INR 42.123 million and net profit after taxes, minority interest and share of associates of INR 30.379 million or INR 1.98 per diluted share after extraordinary items (not annualised) reported in the same period last year. For the quarter, the parent company reported net sales of INR 584.439 million, profit from operations before other income, finance costs and exceptional items of INR 91.7 million, profit from ordinary activities before tax of INR 76.626 million and net profit after taxes, minority interest and share of associates of INR 60.83 million or INR 3.73 per diluted share after extraordinary items (not annualised) compared to net sales of INR 463.706 million, profit from operations before other income, finance costs and exceptional items of INR 64.528 million, profit from ordinary activities before tax of INR 50.718 million and net profit after taxes, minority interest and share of associates of INR 38.461 million or INR 2.36 per diluted share after extraordinary items (not annualised) reported in the same period last year.

Lincoln Pharmaceuticals Ltd Appoints Meha Patel as an Additional Director

Lincoln Pharmaceuticals Ltd. announced that the Board of Directors of the Company at its meeting held on August 04, 2015, has appointed Ms. Meha Patel as an Additional Director (Women Director) to be categorized as an Independent Director.

Lincoln Pharmaceuticals Ltd. to Report Q1, 2016 Results on Aug 04, 2015

Lincoln Pharmaceuticals Ltd. announced that they will report Q1, 2016 results on Aug 04, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LPH:IN 131.20 INR 0.00

LPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LPH.
View Industry Companies
 

Industry Analysis

LPH

Industry Average

Valuation LPH Industry Range
Price/Earnings 11.3x
Price/Sales 0.7x
Price/Book 1.9x
Price/Cash Flow 9.1x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LINCOLN PHARMACEUTICALS LTD, please visit www.lincolnpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.